Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping the biological battlefield of cancer. From the "protective" powers of ...

Yahoo College & High School Sports is powered by On3, delivering expert recruiting, NIL, and transfer portal news. Type 2 diabetes occurs when the body does not use insulin effectively or does not ...

Albertans may see more varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago.

These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...

One of the most commonly known oral T2 diabetes drugs out there, it’s been around for over two decades now and is often referred to as the “first line of defence” in treating type 2 diabetes.

Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 ...